Trade AXSM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Axsome Therapeutics, Inc. (AXSM) is trading at US$210.63, up 1.35% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$10.88B. Over the past 52 weeks, AXSM has traded between US$112.90 and US$260.19. On Syfe you can trade AXSM with $0 commission and add it to your watchlist.
| Previous close | US$207.82 |
|---|---|
| Market cap | US$10.88B |
| P/E ratio | 88.21 |
| 52-week range | US$112.90 – US$260.19 |
| Volume | 414.73K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Year: 2015
Axsome Therapeutics, Inc. (AXSM) stock is trading at US$210.63, +1.35% from the previous close of US$207.82.
The market cap for Axsome Therapeutics, Inc. (AXSM) stock is approximately US$10.88B.
The price-to-earnings ratio for Axsome Therapeutics, Inc. (AXSM) is 88.21, based on the latest reported earnings.
The 52-week high for Axsome Therapeutics, Inc. (AXSM) stock is US$260.19.
The 52-week low for Axsome Therapeutics, Inc. (AXSM) stock is US$112.90.
Axsome Therapeutics, Inc. (AXSM) does not currently pay a dividend.
Stay on top of AXSM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
